Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7853
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWilding, Corina-
dc.contributor.authorBell, Katharina-
dc.contributor.authorFunke, S.-
dc.contributor.authorBeck, Sabine-
dc.contributor.authorPfeiffer, Norbert-
dc.contributor.authorGrus, Franz-Hermann-
dc.date.accessioned2022-10-05T09:27:18Z-
dc.date.available2022-10-05T09:27:18Z-
dc.date.issued2015-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7868-
dc.description.abstractThe pathogenesis of glaucoma, a common neurodegenerative disease, involves an immunologic component. Changes in the natural autoantibody profile of glaucoma patients were detected, showing not only up-regulated but also down-regulated immunoreactivities. In recent studies we were able to demonstrate that the antibody changes have a large influence on protein profiles of neuroretinal cells. Furthermore we could demonstrate neuroprotective potential of one of the down-regulated antibodies (gamma-synuclein antibody). Anti-GFAP antibody is another antibody found down-regulated in glaucoma patients. Since GFAP expression is intensified in glaucomatous retina, the aim of this study was to detect the effect of GFAP antibodies on neuroretinal cells. This is realized with a viability-test as well as proteomic analysis of cells incubated with GFAP antibodies. Furthermore, possible interaction partners of the GFAP antibody in neuroretinal cells were identified by western blot, mass spectrometry and indirect immunofluorescence staining. We found that the GFAP antibody is able to protect cells from oxidative stress, which is due to changed protein expressions of the actin cytoskeleton. Furthermore we detected a cross-reaction of the antibody to endoplasmic reticulum resident protein 57 on the cell membrane, which seems to lead to a changed signaling in the cells triggering the protective effects.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY-NC-ND*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleGFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57en_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7853-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleJournal of pharmacological sciencesde
jgu.journal.volume127de
jgu.journal.issue3de
jgu.pages.start298de
jgu.pages.end304de
jgu.publisher.year2015-
jgu.publisher.nameThe Japanese Pharmacological Societyde
jgu.publisher.placeTokyode
jgu.publisher.urihttp://dx.doi.org/10.1016/j.jphs.2014.12.019de
jgu.publisher.issn1347-8648de
jgu.publisher.issn1347-8613de
jgu.organisation.placeMainz-
jgu.identifier.pmid25837926-
jgu.subject.ddccode610de
opus.date.modified2018-09-05T09:15:51Z-
opus.subject.dfgcode00-000-
opus.organisation.stringFB 04: Medizin: Augenklinik und Poliklinikde_DE
opus.identifier.opusid51986-
opus.importsourcepubmed-
opus.institute.number0446-
opus.metadataonlyfalse-
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN
opus.affiliatedPfeiffer, Norbert-
opus.affiliatedGrus, Franz-Hermann-
jgu.publisher.doi10.1016/j.jphs.2014.12.019de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
gfap_antibodies_show_protecti-20220914233941934.pdf1.19 MBAdobe PDFView/Open